Inspire Medical Systems (INSP) Gross Profit (2017 - 2026)

Inspire Medical Systems (INSP) has 10 years of Gross Profit data on file, last reported at $176.9 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit rose 3.7% year-over-year to $176.9 million; the trailing twelve-month figure through Mar 2026 stood at $785.1 million (up 10.39% YoY), and the FY2025 full-year result was $778.8 million, up 14.55% from the prior year.
• Gross Profit slipped to $176.9 million in Q1 2026, from $233.0 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $233.0 million in Q4 2025 to a low of $59.4 million in Q1 2022.
• A 5-year average of $147.4 million and a median of $164.5 million in 2023 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit surged 81.9% in 2023 and gained 3.7% in 2026, its largest moves.
• Tracing INSP's Gross Profit over 5 years: stood at $115.7 million in 2022, then soared by 42.08% to $164.5 million in 2023, then grew by 23.88% to $203.7 million in 2024, then rose by 14.37% to $233.0 million in 2025, then fell by 24.07% to $176.9 million in 2026.
• Business Quant data shows INSP's Gross Profit at $176.9 million in Q1 2026, $233.0 million in Q4 2025, and $192.7 million in Q3 2025.